1.775USD+0.85%Mkt Cap: 189.24M $P/E: —Today
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap189.24M $
Enterprise Value75.91M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-44.12M $
Revenue/Share—
Last Price1.775 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees9
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.16
PEG—
EV/EBITDA-2.35
EV/Revenue—
P/S—
P/B13.06
EPS (TTM)-0.57
EPS (Forward)-0.34
52W Range
1.685100% of range1.760
52W High1.760 USD
52W Low1.685 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-1268.86%
ROA-190.08%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.50M $
CapEx (TTM)—
FCF Margin—
FCF Yield20.18%
Net Debt-86.79M $
Net Debt/EBITDA2.69
Balance Sheet
Debt/Equity0.00
Current Ratio1.23
Quick Ratio1.19
Book Value/Sh0.1348 USD
Cash/Share0.9390 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)10.00 USD
Upside (mean)+463.4%
Target Range10.00 USD – 10.00 USD
# Analysts1
Ownership
Shares Out.107.52M
Float81.90M
Insiders15.54%
Institutions11.16%
Short Interest
Short Ratio7.7d
Short % Out.5.11%
Shares Short4.51M
Short (prev mo.)4.06M
Technical
SMA 501.821 (-2.5%)
SMA 2003.393 (-47.7%)
Beta—
S&P 52W Chg21.00%
Avg Vol (30d)253.02K
Avg Vol (10d)405.36K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—